8æ19æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.66%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
Gilead Sciences Inc (GILD) å€åãã¯3.66%äžæããŸãããå»è¬å & å»çç ç©¶ã»ã¯ã¿ãŒã¯4.08%äžæããŠããŸãããã®äŒæ¥ã¯æ¥çå¹³åãäžåããŸãããã»ã¯ã¿ãŒå ã®å£²è²·ä»£éäžäœ3éæïŒModerna Inc (MRNA) äžæ 144.04%ãEli Lilly and Co (LLY) äžæ 4.77%ãMerck & Co Inc (MRK) äžæ 12.87%ã

æ¬æ¥ã®Gilead Sciences IncïŒGILDïŒã®æ ªäŸ¡äžæã®èŠå ã¯äœã§ããïŒ
ã®ãªã¢ãã»ãµã€ãšã³ã·ãºã¯ãäž»åäºæ¥ã«ããããã¡ã³ãã¡ã³ã¿ã«ãºã®å 調ãã奜æçãªãªãµãŒãã¢ããããŒããäž»èŠæ²»çè¬ã«é¢ããèŠå¶äžã®å¥œææãªã©ãè€åçã«å¯äžããå èª¿ãªæ ªäŸ¡ã¢ã¡ã³ã¿ã ãèŠããŸãããå瀟ã¯ãã€ãªå»è¬åã®å€§æã§ãããåžå ŽããªãŒãããHIVããŒããã©ãªãªã®æé·å éã«å ããããé åããã³èçŸæ£æ²»çè¬ã®å£²äžæ¡å€§ã«ãã£ãŠããŒã¹ããžãã¹ã®å£²äžé«ãäºæ³ãäžåã£ã第2ååææ±ºç®ãåããåžå Žå¿çãããã«åŒ·åãããŸãããçµå¶é£ã¯HIVäºæ¥ã®éæå£²äžé«æé·èŠéããåŒãäžããŠãããããã¯ã¿ã«ãïŒBiktarvyïŒããªã©ã®äž»èŠæ²»çè¬ã«ãããå 調ãªè²©å£²å®çžŸãã幎2åæäžã®æ³šå°è£œå€ãã€ãšãºããŽïŒYeztugoïŒãã®æ¥éãªæ®åã瀺ããŠããŸãã
æè³å®¶å¿çãããã«é«ããèŠå ãšããŠããŠã©ãŒã«è¡ã®ãªãµãŒãã¢ããªã¹ãã第3ååæã®è¶³å ã®æ¥çžŸäºæ³ãåŒãäžããããšãæããããŸããã¢ããªã¹ããã¯ãçŽè¿ã®ãã€ãã©ã€ã³è²·åã«äŒŽãçæçãªçµ±åè²»çšãæ²éåããã«ã€ããç²çæ§ãããå©ççã®é«ãåçæºãšå¥œèª¿ãªãã£ãã·ã¥ãããŒåµåºåãé¡èã«ãªããšææããŠããŸãããŸããäž»èŠãªHIVæ²»çè¬ã®æµ·å€ããã®èŒžå ¥ã黿¢ããé£éŠè£å€æã®å·®æ¢åœä»€ãªã©ãæ³çãªé²å±ãå瀟ã®ã³ã¢åžå Žã·ã§ã¢ãä¿è·ããããšãšãªããã»ã¯ã¿ãŒã®ä¿¡é Œæãäžæ®µãšé«ããŸãããããã«åžå Žåå è ã¯ãåäžé åé ã®HIVé åå€ã«å¯ŸããŠç±³åœFDAãåªå 審æ»äžã§èšå®ããŠãã審æ»å®äºç®æšæ¥ã®å°æ¥ãªã©ãè¿ãæ§ããèŠå¶äžã®ææ°æ å ±ãæåŸ ããŠããŸãã
äºåèšå®ãããååŒèšç»ã«åºã¥ã圹å¡ã®å®äŸçãªæ ªåŒå£²åŽããã€ãªããã¯ã»ã¯ã¿ãŒå šè¬ã®èª¿æŽã«äŒŽãæ¥äžã®ãã©ãã£ãªãã£ã¯èŠããããã®ã®ãæ©é¢æè³å®¶ã«ããè²·ãéãã瀺ãè¯å¥œãªæ å ±é瀺ãè²·ãè¶ããæ¯ããŸããã匷åãªããªãŒãã£ãã·ã¥ãããŒåµåºåãšç¶ç¶çãªå¢é ãéããæ ªäž»éå å§¿å¢ã¯ãå²å®æãéèŠããæ©é¢æè³å®¶ãåŒãã€ãç¶ããŠããŸããæŠç¥çãªããé åããã³èªå·±å ç«çŸæ£ã®è²·åã«äŒŽãè² åµæ¯çã®é«æ¢ãŸãã¯äºæ¥éå¶äžã®æ€èšäºé ãšããŠæ®ããã®ã®ãåžå Žã¯äž»ã«ã®ãªã¢ãã®å åºãªæ¥çžŸåºç€ãšæ¡å€§ããèšåºãã€ãã©ã€ã³ã®ã«ã¿ãªã¹ãïŒå¥œææïŒã«æ³šç®ããŸããã
Gilead Sciences IncïŒGILDïŒã®ãã¯ãã«ã«åæ
æè¡çã«èŠããšãGilead Sciences Inc (GILD)ã¯MACDïŒ12,26,9ïŒã®æ°å€ã1.872ã§ãè²·ãã®ã·ã°ãã«ã瀺ããŠããŸããRSIã¯69.463ã§äžç«ã®ç¶æ ãWilliamsïŒ Rã¯2.883ã§è²·ããéãã®ç¶æ ã瀺ããŠããŸãããæ³šæãã ããã
Gilead Sciences IncïŒGILDïŒã®ã¡ãã£ã¢å ±é
ã¡ãã£ã¢å ±éã«é¢ããŠãGilead Sciences Inc (GILD)ã¯ã¡ãã£ã¢æ³šç®åºŠã¹ã³ã¢40ã瀺ããŠãããã¡ãã£ã¢æ³šç®åºŠã¯äœãã¬ãã«ã§ããå šäœã®åžå Žã»ã³ãã¡ã³ãææ°ã¯çŸåšäžç«ãŸãŒã³ã«ãããŸãã

Gilead Sciences IncïŒGILDïŒã®ãã¡ã³ãã¡ã³ã¿ã«åæ
Gilead Sciences Inc (GILD)ã¯å»è¬å & å»çç ç©¶æ¥çã«å±ããŠããŸããææ°ã®å¹Žé売äžé«ã¯$29.44Bã§ãæ¥çå ã§15äœã§ããçŽå©çã¯$8.51Bã§ãæ¥çå ã§ã¯8äœã§ããäŒç€ŸæŠèŠ

éå»1ãæã§è€æ°ã®ã¢ããªã¹ããå瀟ãè²·ããšè©äŸ¡ããŸãããç®æšæ ªäŸ¡ã®å¹³åã¯$157.79ãæé«ã¯$180.00ãæäœã¯$123.00ã§ãã
Gilead Sciences IncïŒGILDïŒã«é¢ãã詳现
äŒæ¥åºæã®ãªã¹ã¯ïŒ
- è²·åã«äŒŽãæ¥çžŸã®äžæŒãå§åããã³æžæïŒè¿å¹Žã®ååŒã«ãããåèš115åãã«è¶ ã®å€§å¹ ãªä»æç ç©¶éçºïŒIPR&DïŒäžæè²»çšãã129åãã«ã®éçŸéè³ç£æžææå€±ã®èšäžãGAAPå©çãå€§å¹ ã«æŒãäžããŠãããçµå¶é£ã¯éæç޿倱ã®èŠéããäœåãªããããŠããŸãã
- HIVãã©ã³ãã£ã€ãºãžã®é«ã売äžäŸå床ïŒå šè£œå売äžé«ã®70%以äžããã¯ã¿ã«ãïŒBiktarvyïŒããã¹ã³ãïŒDescovyïŒãªã©ã®äž»åHIVæ²»çè¬ã«äŸåãç¶ããŠãããåŸçºå»è¬åã®è åšãäŸ¡æ Œå§åããããŠ2030幎代åã°ã«æ§ããç¹èš±ç¬å æš©ã®å€±å¹ã«ãããããžãã¹ã¢ãã«ã¯å£²äžé«ã®å€§å¹ ãªå€åãªã¹ã¯ã«æãããŠããŸãã
- 现èçæ³éšéã®çž®å°ãšãã€ãã©ã€ã³ã®åæ»ïŒåžå Žç«¶äºã®æ¿åã«ãã现èçæ³ã®å£²äžé«ã¯åå¹Žåææ¯ã§12%æžå°ããã»ããããŒãããŒã§ããã¢ãŒã«ã¹ã»ãã€ãªãµã€ãšã³ã·ãºïŒArcus BiosciencesïŒã«ããèºããæ²»éšãSTAR-121ãã®äžæãã¯ãããšããå ±åéçºã®é颚ããããé åã«ãããäºæ¥å€æ§åã®åãçµã¿ãè ãããŠããŸãã
- 圹å¡ã«ããç¶ç¶çãªèªç€Ÿæ ªå£²ãïŒForm 144èŠå¶éç€ºææžã«ãããæé«è²¡å責任è ïŒCFOïŒã¢ã³ããªã¥ãŒã»ãã£ããã³ãœã³æ°ã«ããç¶ç¶çãªèªç€Ÿæ ªå£²ããè©³çŽ°ã«æããã«ãªã£ãŠãããå瀟ãåçæ§ã®èª²é¡ã«çŽé¢ããäžã§æ©é¢æè³å®¶ã®èŠææãé«ããŠããŸãã
ãã®èšäºã®äžéšã¯AIã«ãã£ãŠçæã»ç¿»èš³ããã人éã«ããã¬ãã¥ãŒãçµãŠããŸããããã¯äžè¬çãªæ å ±æäŸã®ç®çã§ã®ã¿äœ¿çšãããŠãããæè³ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸããã
ããããèšäº








ã³ã¡ã³ã (0)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã